🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial is to find out the best dose, possible benefits and/or ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2022-01-18
Trial ID
NCT04780568
This study will be conducted in 2 parts. The first part is a phase 1 single...
Status
Recruiting
Location
City of Hope
Start Date
2023-09-13
Trial ID
NCT05797805
Treatments Being Tested
Phase I, open-label, non-randomized study to evaluate safety of BC2059 admi...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2018-07-15
Trial ID
NCT03459469
Treatments Being Tested
This trial will evaluate the safety, tolerability, and preliminary efficacy...
Status
Recruiting
Location
Clinical Trials Nurse Navigator
Start Date
2026-02-17
Trial ID
NCT07463599
Treatments Being Tested
The goal of this clinical trial is to define the maximum tolerated dose (MT...
Status
Recruiting
Location
Arthur M. Blank Children's Healthcare of Atlanta
Start Date
2026-01-22
Trial ID
NCT07144254
Treatments Being Tested
This phase I trial is to find out the best dose and side effects of tegaviv...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-27
Trial ID
NCT04874480
Treatments Being Tested
This phase I/II trial evaluates the highest safe dose, side effects, and po...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-11-08
Trial ID
NCT04851119
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of tegaviv...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-03-06
Trial ID
NCT05755087